Back to ALKS

Affinity Asset Advisors, LLC → ALKS

Affinity Asset Advisors, LLC ALKS Position History

Alkermes plc

Quarters held
6
Latest value
$24.9M
Q3 2026
Peak value
$63.4M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$28M
Q1 2026$47.7M
Q2 2026$58.9M
Q2 2026$13.1M
Q3 2026$63.4M
Q3 2026$24.9M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$24.9M615.4K——
Q3 2026$63.4M1.56M——
Q2 2026$13.1M250.0K——
Q2 2026$58.9M1.13M——
Q1 2026$47.7M1.35M——
Q4 2025$28M1.00M——

Other funds holding ALKS

Other Affinity Asset Advisors, LLC positions

ROIV

ROIVANT SCIENCES LTD

$132.7M
APGE

APOGEE THERAPEUTICS INC

$131M
ROIV

ROIVANT SCIENCES LTD

$117M
SYRE

SPYRE THERAPEUTICS INC

$113.9M
SYRE

SPYRE THERAPEUTICS INC

$113.6M
APGE

APOGEE THERAPEUTICS INC

$108.2M
XENE

XENON PHARMACEUTICALS INC

$97.4M
XENE

XENON PHARMACEUTICALS INC

$96.3M